Scientific Publications

Cancer: A medical emergency

Science Direct 2006 July 7
https://doi.org/10.1016/j.mehy.2006.04.032

 

Cancer Treatments Transform Residual Cancer Cell Phenotype

Cancer Cell International 2011 Jan 7
https://cancerci.biomedcentral.com/articles/10.1186/1475-2867-11-1

 

Revisiting Perioperative Chemotherapy: The Critical Importance of Targeting Residual Cancer Prior to Wound Healing

BMC Cancer 2009 April 22
https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-9-118

 

Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells

Drug Design Development and Therapy 2020 October 8
https://doi.org/10.2147/DDDT.S264122

 

Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases.

Cancers 2022 July 23
https://doi.org/10.3390/cancers14153595

 

Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression.

Cancers 2022 March 8
https://doi.org/10.3390/cancers14061374

 

Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome.

cells 2023 May 7
https://doi.org/10.3390/cells12091332

 

Contemporaneous Perioperative Inflammatory and Angiogenic Cytokine Profiles of Surgical Breast, Colorectal, and Prostate Cancer Patients: Clinical Implications.

cells 2023 December 4
https://doi.org/10.3390/cells12232767

 

Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines and Activates Natural Killer Cell Cytotoxicity.

Vaccines 2025
https://doi.org/10.3390/vaccines13020199

 

Patents

Compositions and Methods for the Treatment of Coronavirus Infections and Respiratory Compromise

Patent Pending – Canada, China, Europe

Compositions and Methods for the Treatment of Threatened Respiratory Failure Caused by Coronavirus Infection and Disease

Patent Pending – USA

Cancer Treatment and Metastasis Inhibition Using Anti-Cancer Stem Cell Agent in Combination with a Neu1 Sialidase Inhibitor after Primary Cancer Treatment

Patent Pending – Canada, Europe